PAVM
PAVM
NASDAQ · Health Care

Pavmed Inc

$10.80
+0.22 (+2.08%)
As of Feb 8, 2:28 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target -33.6% upside
Low Target $4.52
Average Target $7.17
High Target $7.76
Current Price $10.80
Current
$10.80
Target
$7.17
$4.52 $7.17 avg $7.76
Scenario Analysis
Bear Case
$4.52
-58.1%
Low target
Base Case
$7.17
-33.6%
Avg target
Bull Case
$7.76
+-28.1%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$7.47
44.6% from high
52-Week Low
$3.06
+252.9% from low
Target vs 52W High
$7.17
-4.0% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%